Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -85.82% is 50% above its 3-year average of -171.90%, near the high end of its 3-year range (-346.39%–-77.03%).
As of the fiscal period ended Tuesday, June 30, 2026. 63.58% above its 12-month average of -235.61%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -85.82%.
RETURN ON EQUITY (ROE)
-85.82%
RETURN ON EQUITY (ROE) AVG TTM
-235.61%
RETURN ON EQUITY (ROE) AVG 3Y
-179.19%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+63.58%
CURRENT VS 3Y AVG
+52.11%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 532 covered companies
CURRENT VS SECTOR MEDIAN
-113.46%
vs the sector median at left
Bullfrog AI Holdings, Inc. Common Stock
Market Cap
$11.31M
Return on Equity (ROE)
-85.82%
TTM Avg
-235.61%
3Y Avg
-179.19%
5Y Avg
N/A
Market Cap
$11.81M
Return on Equity (ROE)
N/A
TTM Avg
-180.04%
3Y Avg
-6461.50%
5Y Avg
-4315.55%
Market Cap
$11.21M
Return on Equity (ROE)
-37052.06%
TTM Avg
-237.80%
3Y Avg
-258.91%
5Y Avg
-310.30%
Market Cap
$11.38M
Return on Equity (ROE)
-177.35%
TTM Avg
-89.62%
3Y Avg
-75.99%
5Y Avg
-59.80%
Market Cap
$11.30M
Return on Equity (ROE)
-65.18%
TTM Avg
-26.62%
3Y Avg
-94.28%
5Y Avg
-90.35%
Market Cap
$12.69M
Return on Equity (ROE)
N/A
TTM Avg
-162.71%
3Y Avg
-135.96%
5Y Avg
-98.83%
Market Cap
$11.20M
Return on Equity (ROE)
-106.87%
TTM Avg
-250.57%
3Y Avg
-230.96%
5Y Avg
-240.83%
Market Cap
$11.01M
Return on Equity (ROE)
-214.92%
TTM Avg
-46.13%
3Y Avg
-156.76%
5Y Avg
-652.77%
Market Cap
$12.41M
Return on Equity (ROE)
-97.47%
TTM Avg
-90.15%
3Y Avg
-205.18%
5Y Avg
-136.35%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $11.31M | -85.82% | -235.61% | -179.19% | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $11.81M | N/A | -180.04% | -6461.50% | -4315.55% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.21M | -37052.06% | -237.80% | -258.91% | -310.30% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.38M | -177.35% | -89.62% | -75.99% | -59.80% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | -65.18% | -26.62% | -94.28% | -90.35% |
| Cytosorbents Corporation (CTSO)vs › | $12.69M | N/A | -162.71% | -135.96% | -98.83% |
| Biofrontera Inc. (BFRI)vs › | $11.20M | -106.87% | -250.57% | -230.96% | -240.83% |
| BioVie Inc. (BIVI)vs › | $11.01M | -214.92% | -46.13% | -156.76% | -652.77% |
| IRIDEX Corporation (IRIX)vs › | $12.41M | -97.47% | -90.15% | -205.18% | -136.35% |
| Cerenome, Inc. (CNSY)vs › | $10.98M | -477.54% | -207.60% | 64.51% | -22.91% |
ROE
-85.8%
ROA
-77.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -85.82% |
| 2026-03-31 | -124.29% |
| 2025-12-31 | -304.17% |
| 2025-09-30 | -346.39% |
| 2025-06-30 | -317.37% |
| 2025-03-31 | -218.93% |
| 2024-12-31 | -140.89% |
| 2024-09-30 | -172.00% |
| 2024-06-30 | -112.63% |
| 2024-03-31 | -87.21% |
| 2023-12-31 | -206.61% |
| 2023-09-30 | -126.15% |
| 2023-06-30 | -87.06% |
| 2023-03-31 | -77.03% |
